Clinical Pharmacology & Biopharmaceutics
Open Access

Iris Rajman

Global Head PK Sciences, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland

Biography

Dr. Iris Rajman is affiliated to Translational Medicine, Novartis Institutes for Biomedical Research. Dr. Iris Rajman is currently providing services as Professor. Dr. Iris Rajman has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Iris Rajman contributions have acclaimed recognition from honourable subject experts around the world. Dr. Iris Rajman is actively associated with different societies and academies. Dr. Iris Rajman academic career is decorated with several reputed awards and funding. Dr. Iris Rajman research interests include Translational Medicine.

Publications

Assessment of Drug Interaction Potential between LCZ696, an Angiotensin Receptor Neprilysin Inhibitor, and Digoxin or Warfa rin

LCZ696 (sacubitril/valsartan) is a first-in-class angiotensin receptor neprilysin inhibitor that simultaneously inhibits neprilysin and blocks the angiotensin II receptor. LCZ696 has been recently approved for treatment of HF and likely be co-administered with digoxin or warfarin. The drug interaction potential between LCZ696 and digoxin or warfari... Read More»

Surya Ayalasomayajula, Pierre Jordaan, Parasar Pal, Priyamvada Chandra, Diego Albrecht, Thomas Langenickel, Iris Rajman and Gangadhar Sunkara

Research Article: Clin Pharmacol Biopharm 2015, 4:147

DOI: 10.4172/2167-065X.1000147

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF